Lifeboat Foundation

Along with Aubrey de Grey, Stephen L. Sorgner, Rob van Genderen, Paul Nemitz of the European Commission, William Echikson of Center for European Studies, Professor Emeritus Chapel Hill U. Woodrow Barfield, and Anne Zeiter of Ebay, I’ve joined the Editorial board of a new interdisciplinary technology journal called Delphi, published by Lexxion Publisher. They’re looking for papers and abstracts. Give it a read and submit if you like. Here’s the link: http://www.lexxion.de/pdf/delphi/Call_for_Papers_Delphi.pdf

Delft Hyperloop is back, and it claims it’s about to break the speed record for hyperloop. As 20 teams gather in Hawthorne, California, for SpaceX’s third pod racing competition on Sunday, the Netherlands-based group could be one of the key drivers in a transportation revolution.

“Our objective is to go faster than the current record,” Clément Hienen, the team’s design engineer, tells Inverse. “For sure, we designed to break the record.”

It’s a bold claim, especially considering the wider industry. When Elon Musk first released his white paper for a vacuum-sealed-tube-based transportation system in 2013, he claimed pods could fly through at a theoretical maximum speed of 700 mph — cutting a six-hour drive from Los Angeles to San Francisco down to just 30 minutes. Musk’s own firms set a public speed record of 220 mph in August 2017, only for Richard Branson-backed Virgin Hyperloop One to beat the record with 240 mph in December 2017. Delft plans to beat both of these.

Continue reading “How These University Students Plan to Break the Hyperloop Speed Record” »

Learning algorithms which improve how they learn, computers which define their own objectives and then do it, robots which learn from us like children do, its all not far off now.

Panelists:

Continue reading “CogX 2018 — Professor Juergen Schmidhuber Director & Professor, The Swiss AI Lab IDSIA – USI & SUPSI” »

A Chinese artificial intelligence (AI) system has beaten a team of elite doctors in a tumour diagnosis competition.

https://www.youtube.com/watch?v=Di4p6MnN1Eo

This talk by Jordan Pederson suggests human level AGI is here within the year. And after we go expo.

Jordan Peterson’s Links:
Patreon: https://www.patreon.com/jordanbpeterson
Self Authoring: http://selfauthoring.com/
Jordan Peterson Website: http://jordanbpeterson.com/
Podcast: http://jordanbpeterson.com/jordan-b-p…
Reading List: http://jordanbpeterson.com/2017/03/gr…
Twitter: https://twitter.com/jordanbpeterson

Continue reading “Creators of future AI must not be ideologues” »

An Australian scientist is researching new technology which could change the shape of the energy industry worldwide.

A glimpse at the coming AI researchers. (AI’s that do research).

A new type of artificial-intelligence-driven chemistry could revolutionise the way molecules are discovered, scientists claim.

In a new paper published today in the journal Nature, chemists from the University of Glasgow discuss how they have trained an artificially-intelligent organic chemical synthesis robot to automatically explore a very large number of chemical reactions.

Continue reading “Robot chemist discovers new molecules and reactions” »

Vivli, which spun out of a policy think tank at Harvard University–affiliated Brigham and Women’s Hospital in Boston, is part of a push to encourage drug developers to share trial data—even negative results, findings that show a treatment has no benefit. Companies seeking U.S. regulatory approval for a drug, as well as investigators funded by the National Institutes of Health, must post limited, summary results on ClinicalTrials.gov. But many researchers and policy analysts believe sharing detailed raw data on individual patients, stripped of identifying information, would be valuable. Researchers could confirm that a drug works, look for side effects, or explore new questions.

Vivli aims to ease sharing of anonymized clinical studies.

They’re so toxic they can rip your skin apart on contact. But that virulence is what makes them perfect candidates for a new wave of antibiotics.